Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old Recommendation based on a ...

Recommendation based on a Phase 3 trial showing a significantly greater proportion of children on Dupixent achieved histological remission ...

Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old Recommendation based on a phase 3 study showing a significantly greater proportion ...

Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company leveraging its proprietary DiffuSphere technology to ...

Diagnosing EoE can be tricky. There’s no single test, and symptoms like trouble swallowing, chest pain, and heartburn can mimic other conditions. Often, an endoscopy with biopsies, where a tiny tissue ...

The major differential diagnoses of eosinophilic esophagitis are GERD and peptic strictures. Table 1 describes the differences between GERD and eosinophilic esophagitis. The clinical history ...

Before the FDA approved AstraZeneca’s Fasenra, Nucala was the only therapy for treating eosinophilic granulomatosis with ...

First described nearly 20 years ago, eosinophilic esophagitis (EoE) is an inflammatory disease of the esophagus characterized by eosinophilic infiltration of the esophageal epithelium. Over 50% of ...

Many parents struggle with school lunches when their kids have multiple food allergies. The information may also help with ...

Fasenra was approved in 2017 but AZ came up short in its attempts to expand its label to chronic obstructive pulmonary ...

SNY's reasonable valuation, rising estimates, improving top line and positive pipeline progress are good enough reasons to ...

A condition known as eosinophilic esophagitis, or EoE, affects one in 1,500 kids. They actually have an allergic reaction ...